Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...